91 related articles for article (PubMed ID: 23037685)
1. Aripiprazole monotherapy-related gray-matter growth in a patient with first-episode drug-naïve non-psychotic major depressive disorder.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E49-50. PubMed ID: 23037685
[No Abstract] [Full Text] [Related]
2. Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder.
Lai CH
J Clin Psychiatry; 2010 Mar; 71(3):360-2. PubMed ID: 20331938
[No Abstract] [Full Text] [Related]
3. Aripiprazole-related subcortical growth in a patient with major depressive disorder and panic disorder.
Lai CH
J Clin Psychopharmacol; 2010 Aug; 30(4):474-6. PubMed ID: 20631573
[No Abstract] [Full Text] [Related]
4. Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.
Steinhagen CK
Psychosomatics; 2007; 48(4):350-1. PubMed ID: 17600173
[No Abstract] [Full Text] [Related]
5. Aripiprazole monotherapy in a patient with major depressive disorder.
Yokoyama Y; Kitamura H; Someya T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1124-5. PubMed ID: 20398715
[No Abstract] [Full Text] [Related]
6. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
[TBL] [Abstract][Full Text] [Related]
7. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
Wisniewski SR; Chen CC; Kim E; Kan HJ; Guo Z; Carlson BX; Tran QV; Pikalov A
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
[TBL] [Abstract][Full Text] [Related]
8. Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder.
Pae CU
Psychiatry Clin Neurosci; 2009 Aug; 63(4):593. PubMed ID: 19659566
[No Abstract] [Full Text] [Related]
9. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
10. Central sleep apnea in a geriatric patient treated with aripiprazole.
Kohen I; Sarcevic A
Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole as an adjunctive treatment for refractory major depression.
Hellerstein DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1347-8. PubMed ID: 15588762
[No Abstract] [Full Text] [Related]
12. Aripiprazole for the treatment of involuntary movement symptoms in patients with major depressive disorder.
Kang WS; Park JK; Cho AR
J Neuropsychiatry Clin Neurosci; 2012; 24(4):E5-6. PubMed ID: 23224486
[No Abstract] [Full Text] [Related]
13. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
14. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
Grant MJ; Baldessarini RJ
Ann Pharmacother; 2005 Nov; 39(11):1953. PubMed ID: 16219895
[No Abstract] [Full Text] [Related]
15. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
Goforth HW; Carroll BT
J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
[No Abstract] [Full Text] [Related]
16. Brain morphology changes in a remitted patient with late-onset, drug-naïve, non-psychotic major depressive disorder after amisulpride monotherapy.
Hou YC; Lai CH
J Neuropsychiatry Clin Neurosci; 2013; 25(2):E59-60. PubMed ID: 23686069
[No Abstract] [Full Text] [Related]
17. [Use of aripiprazole in the treatment of catatonia].
Vörös V; Tényi T
Neuropsychopharmacol Hung; 2010 Jun; 12(2):373-6. PubMed ID: 20606247
[TBL] [Abstract][Full Text] [Related]
18. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
Tsai AC
J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
[No Abstract] [Full Text] [Related]
19. Aripiprazole in refractory depression?
Carroll BJ
J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
[No Abstract] [Full Text] [Related]
20. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
